Twitter Linkedin Youtube Campus Rubió
Laboratorios Rubió is a company that
is currently undergoing a process of expansion

Business
development

Home / Business development
GENERAL INFORMATION SPHERES OF ACTIVITY GROUP COMPANIES INTERNATIONAL R&D&i PRODUCTION CENTRE TRANSFER OF VALUE
Since 1968

GENERAL INFORMATION

Laboratorios Rubió is a company that is currently
undergoing a process of expansion and growth

TURNOVER:

(in thousands of €)

Total sales National International

GROWTH IN RECENT YEARS:

Laboratorios Rubió is a company in the process of expansion and growth. Ascending progression of turnover is an indicator of the good work done. Our strategic plan focuses on internationalization and R&D for the development of new products.

The turnover of 2022 totaled € 107,5 million, representing an annual increase of 38,3%. By markets, in Spain the increase has been 15,9% and 9,6% internationally.

2023 is expected to continue the growth in turnover reaching 110.2 M€, 2,5%.

EMPLOYEES:

The company’s staff is made up of 193 people—29,5% more than in 2022—with the greatest amount of growth happening in the sales and industrial operations departments.

Laboratorios Rubió is a company that places its trust in the people who make up its organisation, recognises their professional value and dedicates resources to ensure that a good working environment is maintained by fostering opportunities, personal development and a good work-life balance.

2022 Total:193
+30
2021 Total:163
+8
2020 Total:155
+2
2019 Total:153
+4
2018 Total:149
+12

GENERAL INVESTMENTS:

IWithin the company’s strategic plan to continue growing and promoting internationalization, in 2021 Laboratorios Rubió acquired the company Fisiopharma, specialized in nutraceuticals, betting on the food supplements market.

Laboratorios Rubió concentrates its investments on expanding production capacity and on R&D. In 2021, the expansion of the production facilities has begun, which in three years will allow us to practically double our capacity. We also continue to invest in various R&D projects for both the European and US markets.s.

Investments (in thousands of €)

 

Consolidated in the market

SPHERES OF
ACTIVITY

Two major areas of Pharmaceutical and In-vitro Diagnosis
and nutrition for special conditions.

The activity of Rubió Laboratories is structured in two major areas of Pharmaceutical and In-vitro Diagnosis and nutrition for special conditions.

It has a large vademecum of medicines focused mainly on the therapeutic areas of Nephrology, Central Nervous System, Urology, Rheumatology, Cardiovascular Risk and Gynecology.

The company produces and sells medicines already consolidated in the market that have a solid reputation while introducing new products each year that arise both from their own development and from the agreement with third parties.

This area also encompasses healthcare products, an in-vitro diagnostic test focused on the determination of lipoprotein fractions (size / number) to determine cardiovascular risk, and development of complete formulas for the management of malnutrition in patients with chronic kidney disease.

Our mission is to assist
in improving peoples’ quality of life

GROUP COMPANIES
AND INVESTEES

PRODUCTS & TECHNOLOGY:

Created in 2014, this subsidiary acts as a “patent box” in order to boost the Laboratorios Rubió’s R&D&i department. Within this sphere of activity, the company’s number one strategy is based on expanding the lifecycle of their own products, collaborating in new research programmes whose goals tie in with the company’s own therapeutic goals, and establishing strategic alliances with research foundations in related fields.

BIOSFER TESLAB:

Biosfer Teslab, a spin-off of the Universidad Rovira i Virgili (URV) and the Institut d’Investigació Sanitària Pere Virgili (IISPV), is one of Laboratorios Rubió’s investee companies, which specialises in developing in vitro diagnostic tests to improve cardiovascular assessment in high-risk patients.

FISIOPHARMA:

A national company specializing in nutraceuticals aimed at musculoskeletal health, which will grow in the coming years both in products from other therapeutic areas and in other countries.

Laboratorios Rubió is enjoying business
relationships in more than 60 countries

INTERNATIONAL

Countries with sales Countries under registration procedures

INTERNATIONAL:

Laboratorios Rubió carries out a high volume of international sales, currently enjoying business relationships in more than 60 countries and with a network of more than 80 partners worldwide. In this area, the pharmaceutical company has developed a variety of projects with strategic partners in its sector, allowing it to set very high goals for growth in the coming years.

International business makes up more than 70% of the total number of the company’s manufactured units, showing significant growth in recent years. For the company, the development of new markets is a priority in order to consolidate its activity and stimulates projections for future growth.

Countries with sales:

  • Albania
  • Algeria
  • Andorra
  • Angola
  • Argentina
  • Australia
  • Botswana
  • Canada
  • Chile
  • Colombia
  • Costa Rica
  • Croatia
  • Cuba
  • Cyprus
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • El Salvador
  • Estonia
  • Finland
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Guinea
  • Honduras
  • Hong Kong
  • Hungary
  • Iran
  • Iraq
  • Israel
  • Kosovo
  • Kuwait
  • Lebanon
  • Lithuania
  • Malaysia
  • Malta
  • Mauritius
  • Mexico
  • Moldova
  • Morocco
  • Netherlands
  • New Zealand
  • Nicaragua
  • Norway
  • Pakistan
  • Panama
  • Poland
  • Portugal
  • Romania
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovenia
  • South Africa
  • Sri Lanka
  • Sudan
  • Suriname
  • Sweden
  • Thailand
  • Trinidad and Tobago
  • The Philippines
  • Tunisia
  • Turkey
  • UAE
  • UK
  • Uruguay
  • US
  • Vietnam

Countries under registration procedures:

  • Bangladesh
  • Bolivia
  • China
  • Jordan
  • Myanmar
  • Peru

R&D&i

With the recent acquisition of OWL Metabolomics, the company takes a prominent position in the metabolomics sector, with its own developments of diagnostic tests based on metabolomics and developments and studies for the pharmaceutical industry and main research centers. The knowledge generated in one of the most innovative “omics” sciences today, in liquid chromatography and mass spectrometry (LC/MS) platforms, is key for internal research projects as well as for third parties. to diseases with a high component of metabolic syndrome and liver diseases. In turn, the complementary technologies of Biosfer Teslab and OWL Metabolomics provide robustness to the company’s metabolomics offer.

More than 10 million units of
finished product per year

PRODUCTION
CENTRE

Laboratorios Rubió has its own state-of-the-art production plant located in the town of Castellbisbal, in the province of Barcelona. Built over 2900 square metres, and an installed capacity to produce more than 10 million units of finished product per year, this centre is equipped with the top technology, giving it the capacity to prepare oral solid dosage forms— particularly tablets, coated tablets, capsules and single-dose and multi-dose powders—as well as primary and secondary packaging for these pharmaceutical forms, in accordance with GMP guidelines.

Within these facilities, the quality control and pharmaceutical development labs are also housed, along with a pilot plant necessary to carry out the industrial-level scaling processes, and the finished product warehouses.

This plant is continuously undergoing renovations, with an annual investment plan that includes the improvement and replacement of equipment and facilities, with the objective of meeting the highest quality and productivity standards.

Commitment and transparency

TRANSFER OF VALUE

COMMITMENT:

Laboratorios Rubió is a company whose commitment to transparency is strengthened through the disclosure, as stated in Spanish Farmaindustria’s Code of Best Practices, of transfers of value occurring each year as a result of interactions with healthcare organisations and professionals.


TRANSFER OF VALUE REPORTS:


Healthcare Professionals (HCP) Individual 2020 Download

Healthcare Professionals (HCP) Individual 2021 Download

Healthcare Professionals (HCP) Individual 2022 Download

Health Organizations Individual 2020 Download

Health Organizations Individual 2021 Download

Health Organizations Individual 2022 Download

Methodology 2020 Download

Methodology 2021 Download

Methodology 2022 Download
Home / Business development
Scroll up
We want everyone to have access to our medicines wherever they are, regardless of prevalence.
OUR PRODUCTS
Las cookies son importantes para usted, influyen en su experiencia de navegación, nos ayudan a proteger su privacidad y permiten realizar las peticiones que nos solicite a través de la web. Utilizamos cookies propias y de terceros para analizar nuestros servicios y mostrarle publicidad relacionada con sus preferencias en base a un perfil elaborado con sus hábitos de navegación (por ejemplo, páginas visitadas). Si consiente su instalación pulse "Aceptar cookies", o también puede configurar sus preferencias pulsando "Configurar cookies". Más información en nuestra " Política de cookies"
Configurar cookies Aceptar cookies
Panel de configuración de cookies

Este es el configurador avanzado de cookies propias y de terceros. Aquí puede modificar parámetros que afectarán directamente a su experiencia de navegación en esta web.

Cookies Técnicas (necesarias)

Estas cookies son importantes para darte acceso seguro a zonas con información personal o para reconocerte cuando inicias sesión. Consultar Listado de Cookies Técnicas

Cookies de Personalización

Estas cookies están relacionadas con características generales como, por ejemplo, el navegador que utiliza, y podrá disponer de una experiencia y contenidos personalizados.Consultar Listado de Cookies de Personalización

No quiero cookies de Personalización (Con su selección no podemos ofrecerle una navegación y contenidos personalizados)
Cookies Analíticas

Permiten medir, de forma anónima, el número de visitas o la actividad. Gracias a ellas podemos mejorar constantemente su experiencia de navegación. Podrá disponer de una mejora continua en la experiencia de navegación.Consultar Listado de Cookies Analíticas

No quiero cookies Analíticas (Con su selección no podemos ofrecerle una mejora continua en la experiencia de navegación)
Guardar configuración